Breaking News Instant updates and real-time market news.

CVS

CVS Health

$81.68

-1.42 (-1.71%)

, WBA

Walgreens Boots Alliance

$81.21

-1.39 (-1.68%)

14:20
09/20/17
09/20
14:20
09/20/17
14:20

Pharmacies drop after Leerink says Amazon talking to PBMs

After speaking with management teams of AmerisourceBergen (ABC) and Cardinal Health (CAH), Leerink analyst David Larsen said in a research note earlier today that he was surprised to hear Amazon (AMZN) "may indeed be in conversations with some middle-market PBMs now, in an effort to get into various contract arrangements." PBMs, or pharmacy benefit managers, include Express Scripts (ESRX) and UnitedHealth (UNH). Amazon likely has the ability to go after "cash paying" customers now, and while this segment of the market may be just 5%-10% of total, it can still be material, Larsen wrote. He points out that when Walgreens Boots Alliance (WBA) captured 40M prescriptions from CVS, or less than 2% of total PBM and retail scripts, the unfavorable earnings impact was significant. In order for Amazon to be licensed in 50 states, Leerink's specialist thinks it would take 18-24 months to get all of the paperwork completed. The specialist, however, believes there would be minimal impact from Amazon on the PBMs. After Axios highlighted Larsen's research note in an afternoon post on its website, shares of pharmacy owners CVS Health and Walgreens fell around 2%. Express Scripts is up 1% to $61.89 in afternoon trading.

CVS

CVS Health

$81.68

-1.42 (-1.71%)

WBA

Walgreens Boots Alliance

$81.21

-1.39 (-1.68%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

ESRX

Express Scripts

$61.00

-1.01 (-1.63%)

ABC

AmerisourceBergen

$78.74

-0.54 (-0.68%)

CAH

Cardinal Health

$66.44

0.179 (0.27%)

  • 21

    Sep

  • 22

    Sep

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

CVS CVS Health
$81.68

-1.42 (-1.71%)

08/28/17
NEED
08/28/17
NO CHANGE
NEED
Amazon, Whole Foods combined company not an incremental competitor, says Needham
Needham analyst Kevin Caliendo notes that drug retailers were weak after Amazon (AMZN) said it would provide its Prime members enhanced benefits while shopping at newly acquired Whole Foods (WFM) and cut prices on certain household staple items inside the grocer. While the analyst understands the Amazon threat will remain for the drug retailers and pharma supply chain, he believes the news should have no material impact on revenues or profits at CVS Health (CVS) and Walgreens Boots Alliance (WBA). Caliendo expects that Amazon will continue to try and lever its website and Whole Foods store locations to increase traffic, but he does not yet see the combined company as an incremental competitor beyond what each did separately.
09/14/17
LEER
09/14/17
NO CHANGE
LEER
Minimal hurricane exposure for pharma supply chain, says Leerink
Leerink analyst David Larsen sees less than 1% impact to revenues and earnings to companies in his coverage from Hurricane Harvey and Irma and believes any effects will be viewed as one-time in nature. The analyst notes that "the percentage of state impacted" and "days of impact" are particularly challenging variables in his model to estimate, but based on various assumptions he believes the hurricanes will prove to be a minor event for Express Scripts (ESRX), AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK). Nonetheless, Larsen says pharmacy retailers Walgreens Boots Alliance (WBA) and CVS Health (CVS) may face some store closures and possible damage costs.
09/19/17
RBCM
09/19/17
INITIATION
RBCM
Outperform
CVS Health initiated with an Outperform at RBC Capital
RBC Capital analyst George Hill started coverage of CVS with a $95 price target and an Outperform rating. He thinks that the company "could transform itself" by merging with a health insurance company, although he says that the chances of such a deal are "low." He estimates that such a deal could increase the company's EPS by over 10% and cause its multiple to rise by 200%-400%. Hill says that the stock's valuation is attractive even if the company does not make a deal.
09/19/17
09/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform at Jefferies. 2. DowDuPont (DWDP) initiated with a Buy at Argus. 3. Intuit (INTU) initiated with an Outperform at William Blair. 4. CVS Health (CVS) initiated with an Outperform at RBC Capital. 5. athenahealth (ATHN) initiated with a Sector Perform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
WBA Walgreens Boots Alliance
$81.21

-1.39 (-1.68%)

09/07/17
WELS
09/07/17
NO CHANGE
WELS
Market Perform
Perrigo signaled willingness to work with Amazon, says Wells Fargo
Wells Fargo analyst David Maris noted that while presenting yesterday at the firm's conference, Perrigo (PRGO) said it would welcome working with Amazon on store brands. Currently, online sales partnerships with e-commerce arms of existing retailers, such as Walmart (WMT) and Walgreens (WBA), account for 1% of Perrigo products, he added. Maris, who said the company made an "upbeat and confident presentation," keeps a Market Perform rating on Perrigo shares.
09/19/17
RBCM
09/19/17
INITIATION
RBCM
Outperform
Walgreens Boots Alliance initiated with an Outperform at RBC Capital
RBC Capital analyst George Hill started coverage of Walgreens with a $96 price target and an Outperform rating. The analyst says that the company is poised to generate " industry leading volume growth that should lead to accelerating EPS growth." He expects the company's EPS to come in significantly above the consensus outlook.
AMZN Amazon.com
$969.86

-4.33 (-0.44%)

09/20/17
KEYB
09/20/17
NO CHANGE
KEYB
Toys R Us bankruptcy positive for Wal-Mart, Amazon, says KeyBanc
KeyBanc analyst Edward Yruma views the Toys R Us (TOY) bankruptcy as positive for both Wal-Mart (WMT) and Amazon (AMZN). The analyst believes that Wal-Mart's toy and baby business is over two times Toys R Us' domestic business and that its relative importance to the toy companies will only increase. Meanwhile, Yruma thinks Amazon's growth and convenience will drive continued share gains as well.
09/20/17
SBSH
09/20/17
NO CHANGE
Target $51
SBSH
Buy
Citi likes Kohl's swimming with the 'shark,' boosts target to $51
Citi analyst Paul Lejuez raised his price target for Kohl's (KSS) to $51 after the company announced its second partnership with Amazon (AMZN) this month. The collaboration, at a time when department stores are struggling, shows that Kohl's management is thinking out of the box, Lejuez tells investors in a research note. He believes the partnership can work to improve traffic. It is "better to be the 'pilot fish' that swims with the 'shark' than to be hunted by the shark," the analyst contends. He keeps a Buy rating on Kohl's.
09/20/17
NRCS
09/20/17
NO CHANGE
NRCS
Henry Schein and Patterson concerns overdone, says Northcoast
Northcoast analyst Ed Snyder said Henry Schein (HSIC) and Patterson Companies (PDCO) have traded significantly lower in the past week due to concerns Amazon.com will increase exposure to the dental market. Snyder's research indicates Amazon is sourcing product from unsustainable sources including grey market sellers and privately-held Arnold Dental Supply, and not from large dental product manufacturers directly. He expects Arnold Dental to face increasing pressure from manufacturers who are annoyed product s are being sold via Amazon and notes many are not currently filling orders to replenish inventory. Further, Snyder said dentists value equipment service and support offered by traditional distributors far more than price discounts.
09/19/17
KEYB
09/19/17
NO CHANGE
KEYB
KeyBanc remains positive on Activision Blizzard, Electronic Arts
KeyBanc analyst Evan Wingren remains positive on Activision Blizzard (ATVI), Electronic Arts (EA), and Take-Two (TTWO) after attending eSCon, a small eSports conference in Los Angeles. The analyst believes interest and momentum in the space remains high, and continues to think the majority of the economics in the industry will accrue to IP owners and scaled technology partners. Therefore, Wingren continues to see the publishers as well-positioned, as well as Amazon's (AMZN) Twitch, Google's (GOOG; GOOGL) YouTube, and Facebook (FB).
ESRX Express Scripts
$61.00

-1.01 (-1.63%)

07/28/17
WELS
07/28/17
NO CHANGE
Target $9
WELS
Underperform
Insurers are dropping Valeant's top products, says Wells Fargo
United Healthcare's (UNH) formulary is no longer covering Valeant Pharmaceuticals' (VRX) number three branded drug Solodyn and will also now exclude Retin-A brand, its number four branded drug, Wells Fargo analyst David Maris tells investors in a research note. The analyst estimates the two drugs represented approximately $214M of Valeant's sales in 2016. Maris also points out that Glumetza, Valeant's number eight branded drug, and Relistor were removed in July from CVS/Caremark's (CVS) formulary. These two drugs had approximately $119M in 2016 revenues. Maris notes his counterpart Peter Costa estimates that United Healthcare covers approximately 17% of the U.S. and CVS covers approximately 33%. Express Scripts (ESRX) is releasing its 2018 national formulary next week, Costa adds. Maris keeps an Underperform rating on shares of Valeant with a $9 price target. The stock in premarket trading is down 33c, or 2%, to $16.80.
06/27/17
BARD
06/27/17
NO CHANGE
Target $20
BARD
Outperform
Diplomat Pharmacy and entire supply chain have reimbursement risk, says Baird
Baird analyst Eric Coldwell noted Diplomat Pharmacy (DPLO) shares were lower yesterday based on a competitor's research note that suggested Express Scripts (ESRX) was cutting reimbursement in certain commercial plans and is kicking the tires on a DIR rollout in Part D. The analyst believes that would be not only negative for Diplomat but for all in the supply chain. The fact that others were not hit as hard is confusing to Coldwell, but he hopes for clarification from the company's IR day tomorrow. Coldwell maintained his Outperform rating and $20 price target on Diplomat Pharmacy shares.
09/19/17
RBCM
09/19/17
INITIATION
RBCM
Sector Perform
Express Scripts initiated with a Sector Perform at RBC Capital
RBC Capital analyst George Hill started coverage of Express Scripts (ESRX) with a $68 price target and a Sector Perform rating. The analyst says that the company "faces an uncertain future" in the wake of the loss of its deal with Anthem ( ANTM), as he believes that it will have difficulty generating operating profit growth without Anthem.
ABC AmerisourceBergen
$78.74

-0.54 (-0.68%)

09/19/17
RBCM
09/19/17
INITIATION
RBCM
Sector Perform
AmerisourceBergen initiated with a Sector Perform at RBC Capital
RBC Capital analyst George Hill started coverage of AmerisourceBergen with an $87 price target and a Sector Perform rating.
09/14/17
09/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hertz (HTZ) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Adam Jonas citing the doubling of shares over the last three months and raised its price target to $14 from $12. 2. New Oriental Education (EDU) downgraded to Underweight from Neutral at JPMorgan with analyst Leon Chik saying the downgrade is "purely a valuation call." 3. McKesson (MCK) and AmerisourceBergen (ABC) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Apache (APA) and Imperial Oil (IMO) were downgraded to Underweight from Neutral at JPMorgan, while Hess Corp. (HES) was downgraded to Neutral from Overweight. 5. Ryanair (RYAAY) downgraded to Reduce from Hold at HSBC with analyst Andrew Lobbenberg citing the ECJ ruling against the company's practice of employing flight crew on Irish labor contracts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/14/17
MSCO
09/14/17
DOWNGRADE
Target $91
MSCO
Equal Weight
AmerisourceBergen downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Ricky Goldwater downgraded AmerisourceBergen (ABC) and McKesson (MCK) to Equal Weight from Overweight saying EBIT growth is at risk from increased generic price inflation and a record number of generic drug approvals in the next two years. Goldwater changed his thesis and does not believe pricing pressure will abate soon due to continued generic deflation and increased customer access to pricing information. He thinks it is increasingly likely that one or more distributors "blinks" on price, hurting economics. Goldwater lowered AmerisourceBergen's price target to $91 from $94 and McKesson's price target to $172 from $184.
CAH Cardinal Health
$66.44

0.179 (0.27%)

08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
09/19/17
RBCM
09/19/17
INITIATION
RBCM
Sector Perform
Cardinal Health initiated with a Sector Perform at RBC Capital
RBC Capital analyst George Hill started coverage of Cardinal with a $72 price target and a Sector Perform rating.
08/03/17
FBCO
08/03/17
NO CHANGE
Target $81
FBCO
Outperform
Cardinal Health price target lowered to $81 from $87 at Credit Suisse
Credit Suisse analyst Erin Wilson Wright lowered her price target for Cardinal Health to $81 from $87, citing on a "surprising" cut to 2018 EPS guidance primarily on incremental investment initiatives across its businesses, further defining 2018 as a transition year. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

VBTX

Veritex

$26.94

-0.17 (-0.63%)

05:21
10/24/17
10/24
05:21
10/24/17
05:21
Hot Stocks
Veritex announces branch office sales, terms not disclosed »

Veritex Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:19
10/24/17
10/24
05:19
10/24/17
05:19
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VECO

Veeco

$21.75

0.5 (2.35%)

05:18
10/24/17
10/24
05:18
10/24/17
05:18
Downgrade
Veeco rating change  »

Veeco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:16
10/24/17
10/24
05:16
10/24/17
05:16
Initiation
PQ Group initiated  »

PQ Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRTO

Criteo

$46.14

0.13 (0.28%)

, AAPL

Apple

$156.17

-0.08 (-0.05%)

05:15
10/24/17
10/24
05:15
10/24/17
05:15
Downgrade
Criteo, Apple rating change  »

Criteo downgraded to…

CRTO

Criteo

$46.14

0.13 (0.28%)

AAPL

Apple

$156.17

-0.08 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 02

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:10
10/24/17
10/24
05:10
10/24/17
05:10
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$26.58

0.25 (0.95%)

05:08
10/24/17
10/24
05:08
10/24/17
05:08
Initiation
Tronox initiated  »

Tronox initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:06
10/24/17
10/24
05:06
10/24/17
05:06
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$24.35

-2.82 (-10.38%)

05:04
10/24/17
10/24
05:04
10/24/17
05:04
Recommendations
Arconic analyst commentary  »

Arconic selloff yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PQG

PQ Group

$16.67

-0.2 (-1.19%)

05:01
10/24/17
10/24
05:01
10/24/17
05:01
Initiation
PQ Group initiated  »

PQ Group initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

$20.08

0.01 (0.05%)

04:59
10/24/17
10/24
04:59
10/24/17
04:59
Recommendations
ON Semiconductor analyst commentary  »

ON Semiconductor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TECH

Bio-Techne

$123.88

-0.37 (-0.30%)

04:58
10/24/17
10/24
04:58
10/24/17
04:58
Recommendations
Bio-Techne analyst commentary  »

Bio-Techne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 30

    Nov

ABT

Abbott

$56.08

-0.24 (-0.43%)

, DXCM

Dexcom

$44.77

-0.01 (-0.02%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Analysts discuss…

ABT

Abbott

$56.08

-0.24 (-0.43%)

DXCM

Dexcom

$44.77

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 01

    Nov

  • 06

    Nov

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

, C

Citi

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
eSHOW to hold a conference »

Money 20/20 is being held…

JPM

JPMorgan

$99.34

-0.17 (-0.17%)

C

Citi

CSCO

Cisco

$34.35

0.1 (0.29%)

BLK

BlackRock

$474.39

-2.23 (-0.47%)

BX

Blackstone

$34.72

0.26 (0.75%)

B

Barnes Group

$70.96

-0.93 (-1.29%)

BCS

Barclays

$10.27

-0.04 (-0.39%)

AMZN

Amazon.com

$966.30

-16.61 (-1.69%)

AKAM

Akamai

$51.46

-0.41 (-0.79%)

CS

Credit Suisse

$16.04

-0.06 (-0.37%)

DFS

Discover

$66.84

0.27 (0.41%)

IBM

IBM

$159.55

-2.52 (-1.55%)

INTC

Intel

$40.83

0.4 (0.99%)

SSNLF

Samsung

PAY

Verifone

$19.85

-0.21 (-1.05%)

MA

MasterCard

$145.56

0.18 (0.12%)

SPLK

Splunk

$64.23

0.14 (0.22%)

V

Visa

$107.53

-0.02 (-0.02%)

WFC

Wells Fargo

$54.91

-0.01 (-0.02%)

GOOG

Alphabet

$968.45

-19.75 (-2.00%)

MSFT

Microsoft

$78.83

0.02 (0.03%)

WMT

Wal-Mart

$88.65

1.21 (1.38%)

GS

Goldman Sachs

$242.13

-2.6 (-1.06%)

FB

Facebook

$171.27

-3.71 (-2.12%)

RY

Royal Bank of Canada

$80.19

-0.07 (-0.09%)

T

AT&T

$35.25

-0.29 (-0.82%)

JEF

Bought by LUK

ADBE

Adobe

$172.16

-3.48 (-1.98%)

BAC

Bank of America

$27.16

-0.01 (-0.04%)

DB

Deutsche Bank

$16.63

-0.35 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 17

    Nov

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 11

    Dec

  • 14

    Dec

  • 15

    Jan

  • 20

    Feb

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 04

    May

  • 14

    Jul

  • 12

    Oct

MRK

Merck

$63.40

-0.48 (-0.75%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
World Congress to hold a summit »

5th Annual Patient…

MRK

Merck

$63.40

-0.48 (-0.75%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

AGN

Allergan

$187.77

-0.51 (-0.27%)

ONCE

Spark Therapeutics

$83.69

1.82 (2.22%)

PODD

Insulet

$61.02

-0.56 (-0.91%)

ACHN

Achillion

$4.01

-0.14 (-3.37%)

SNY

Sanofi

$49.62

0.11 (0.22%)

ABEO

Abeona Therapeutics

$18.60

-0.4 (-2.11%)

JNJ

Johnson & Johnson

$143.62

1.22 (0.86%)

AZN

AstraZeneca

$34.39

-0.23 (-0.66%)

SHPG

Shire

$144.78

-0.47 (-0.32%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

BMY

Bristol-Myers

$63.75

-0.67 (-1.04%)

SCMP

Sucampo

$10.10

-0.2 (-1.94%)

PCRX

Pacira

$32.95

-0.55 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

  • 30

    Nov

  • 12

    Jan

  • 02

    Feb

  • 05

    Mar

  • 06

    Apr

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

, CARO

Carolina Financial

$36.80

0.63 (1.74%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.99

0.33 (1.77%)

CARO

Carolina Financial

$36.80

0.63 (1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

ASOMY

ASOS

$73.88

-0.4 (-0.54%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
ASOS management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

AQXP

Aquinox

$12.47

-0.27 (-2.12%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Aquinox management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 07

    Dec

DDAIF

Daimler AG

$80.60

0.03 (0.04%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Daimler AG management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PAY

Verifone

$19.85

-0.21 (-1.05%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Verifone management to meet with Craig-Hallum »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 14

    Dec

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
Breaking General news story  »

Week of 10/21 Redbook to…

04:55
10/24/17
10/24
04:55
10/24/17
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

October PMI Composite…

MTNB

Matinas BioPharma

$1.15

-0.08 (-6.50%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Matinas BioPharma management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
The U.S. Commodity Futures Trading Commission holds a symposium »

25th Annual Symposium is…

SNY

Sanofi

$49.62

0.11 (0.22%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

04:55
10/24/17
10/24
04:55
10/24/17
04:55
Conference/Events
Worldwide Business Research to hold a summit »

BioNetwork Partnering…

SNY

Sanofi

$49.62

0.11 (0.22%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.01

-0.055 (-0.20%)

UNH

UnitedHealth

$207.01

-0.48 (-0.23%)

NVS

Novartis

$85.91

0.17 (0.20%)

HZNP

Horizon Pharma

$13.86

-0.23 (-1.63%)

ABBV

AbbVie

$94.51

-1.59 (-1.65%)

BAYRY

Bayer

$34.51

-0.29 (-0.83%)

MRK

Merck

$63.40

-0.48 (-0.75%)

RDHL

RedHill Biopharma

$9.11

-0.14 (-1.51%)

NBRV

Nabriva Therapeutics

$6.07

-0.26 (-4.11%)

PFE

Pfizer

$36.40

-0.02 (-0.05%)

TEVA

Teva

$14.54

-0.36 (-2.42%)

GILD

Gilead

$80.17

-1.04 (-1.28%)

ALXN

Alexion

$135.20

-3.82 (-2.75%)

GSK

GlaxoSmithKline

$40.62

-0.22 (-0.54%)

REGN

Regeneron

$432.76

-0.22 (-0.05%)

CELG

Celgene

$122.37

1.04 (0.86%)

LLY

Eli Lilly

$87.18

-0.05 (-0.06%)

AMGN

Amgen

$180.53

-2.43 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 13

    Nov

  • 16

    Nov

  • 16

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 04

    Dec

  • 02

    Feb

  • 03

    Feb

  • 12

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.